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In Brief
The large amount of publically available
high-throughput data contains, in
aggregate, a vast amount of
immunologically relevant insight. Sealfon
and colleagues report ImmuNet, a web-
accessible public resource based on
38,088 experiments that allows
researchers to predict gene-gene
relationships relevant to the human
immune system and immunological
diseases.
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Many functionally important interactions between
genes and proteins involved in immunological dis-
eases and processes are unknown. The exponential
growth in public high-throughput data offers an
opportunity to expand this knowledge. To unlock
human-immunology-relevant insight contained in
the global biomedical research effort, including all
public high-throughput datasets, we performed
immunological-pathway-focused Bayesian integra-
tion of a comprehensive, heterogeneous compen-
dium comprising 38,088 genome-scale experiments.
The distillation of this knowledge into immunological
networks of functional relationships between molec-
ular entities (ImmuNet), and tools to mine this
resource, are accessible to the public at http://
immunet.princeton.edu. The predictive capacity of
ImmuNet, established by rigorous statistical valida-
tion, is easily accessed by experimentalists to
generate data-driven hypotheses. We demonstrate
the power of this approach through the identification
of unique host-virus interaction responses, and we
show how ImmuNet complements genetic studies
by predicting disease-associated genes. ImmuNet
should be widely beneficial for investigating the
mechanisms of the human immune system and
immunological diseases.
INTRODUCTION
Many advances in immunology involve the identification of the
functional roles of specific molecular entities (genes or proteins)Imin immunological diseases or immune pathways. These diseases
and pathways emerge from a complex network of relationships
among molecular entities. Numerous immunological disorders,
for example inflammatory bowel disease (IBD), are now recog-
nized to involve multiple genes and processes in the manifesta-
tion of the disease (Jostins et al., 2012). In addition, specific
disease-associated genes can contribute to distinct phenotypes
for different immunological diseases, suggesting the importance
of context-specific functionalization of these genes (Hebbring,
2014). Consequently, improving systems-level knowledge of
each immune process should further the understanding of the
molecular basis for many immunological disorders. Although
immunological research focusing on individual entities has
been invaluable, the underlying genome-scale network of rela-
tionships remains largely unexplored. Mapping the functional
association network of genes and proteins in the context of
immunological processes is an important challenge for human
immunology research.
In recent years, the public availability of high-throughput
experimental data has grown exponentially (Bhattacharya
et al., 2014; Brazma et al., 2003; Edgar et al., 2002; Heng
et al., 2008; Stark et al., 2006). High-throughput experimental as-
says of gene expression, protein physical interaction, and local-
ization have allowed researchers to measure cellular activity
across multiple conditions, tissues, and diverse genetic back-
grounds. In aggregate, these data hold critical insights that
extend beyond the questions addressed in the experiments
used to generate each individual dataset. For example, although
cancer datasets contain rich information relevant to processes
involved in immune surveillance (Dunn et al., 2004), there has
been no practical way to mine them for immunological insight.
Immunology research would benefit by more efficient extraction
of and access to the information relevant to immunological dis-
eases and pathways that is hidden within the global public
data output and that can be resolved through simultaneous anal-
ysis of these thousands of diverse experiments.munity 43, 605–614, September 15, 2015 ª2015 Elsevier Inc. 605
One obstacle to harnessing the potential insight contained in
the global research output for specific immunological ques-
tions is the difficulty of detecting relevant information from a
large body of often conflicting data obtained from diverse ex-
periments and assays. The complexity, heterogeneity, and
variation in quality of high-throughput assays necessitate an
approach that takes these factors into consideration. Integra-
tion and interpretation of this massive collection of datasets
can be addressed by refined Bayesian approaches and
rigorous, well-established statistical validation methods
(Geisser, 1993; Hastie et al., 2011). These have proven
uniquely suitable for extracting relevant information from het-
erogeneous sources, while being robust to noise (Alexeyenko
and Sonnhammer, 2009; Huttenhower et al., 2009; Lee et al.,
2011; Mostafavi et al., 2008; Snel et al., 2000; Troyanskaya
et al., 2003).
The basic approach of Bayesian integration is to first select
known information of the type one is trying to expand, such as
a well-annotated specific immunological pathway. Then, each
dataset in a large data compendium is evaluated for how well
it can be used to reconstruct the targeted pathway. Based on
this calculated accuracy and implied relevance, each dataset
contributes to new predictions of the likelihood of functional
relationships between molecular entities pertinent to the
pathway or process of interest. There are two major advan-
tages of this approach over other methods (e.g., rank aggre-
gation [Kolde et al., 2012] or co-expression linkage [Lee
et al., 2004; Stuart et al., 2003]) for summarizing data. First,
individual datasets that contain no useful information due to
their lack of relevance to the targeted pathway or their quality
are statistically excluded. Second, the approach considers
diverse types of measurements, ranging from global RNA
expression to protein interaction studies, and rigorously
selects the datasets that, in aggregate, best provide new
insight about the pathway of interest. Although integrative
approaches have begun to be applied to human biology (Hoff-
man et al., 2012; Huttenhower et al., 2009; Lee et al., 2011;
Mostafavi et al., 2008; Park et al., 2015; Tasxan et al., 2012;
Troyanskaya et al., 2003), they have not been tailored to the
context of the immune system and immune processes. Such
context-specific integration is necessary to improve the rele-
vance and accuracy of insight that can be obtained (Hutten-
hower et al., 2009). Toward this end, we transformed public
datasets from 38,088 experiments, including genome-scale
expression, physical interaction, and sequence studies, into
an integrated map of immunological relationships among
molecular entities. The resulting comprehensive web-acces-
sible resource (ImmuNet) facilitates researchers’ use of the
global data output to generate testable hypotheses for specific
immunological research areas.
Through rigorous statistical assessments and real immuno-
logical applications, we show ImmuNet’s advantages over
non-immune-specific networks or physical interaction data-
based networks alone. We further demonstrate ImmuNet’s util-
ity in addressing immunological questions by providing insight
into gene signatures associated with virus infection. Finally,
we demonstrate the value and ease of use of ImmuNet to com-
plement genetic studies for identifying disease-associated
genes.606 Immunity 43, 605–614, September 15, 2015 ª2015 Elsevier Inc.RESULTS
Development and Computational Validation of ImmuNet
To develop the data-driven views of the entire immune land-
scape, we built genome-scale networks, each focused on an
individual pathway of central importance to innate or adaptive
immunity. For each of these pathway-based networks, a proba-
bilistic Bayesian approach was used to determine a quantitative
measure of the relevance of each of 1,013 datasets (comprising
38,088 genome-scale experiments). This approach entails se-
lecting a public repository of well-annotated known relationships
between molecular entities relevant for immunology that is then
used as a training set for constructing the network of functional
relationships. Bayesian integration assesses the degree towhich
each individual dataset in the compendium contains evidence
for relationships within the training set and computes a corre-
sponding weight for each dataset in constructing a network for
making novel relevant inferences. The training sets selected for
ImmuNet were the 15 expert-curated Kyoto Encyclopedia of
Genes and Genomes (KEGG) immune-related pathways (Ogata
et al., 1999). The selection of KEGG pathways for training Immu-
Net was based on the superiority of the integrated networks ob-
tained. As described in the Computational Methods, evaluation
of the predictive capacity of networks based on two other pub-
lically available annotation and pathway repositories, the im-
mune annotations in Gene Ontology (GO) (Harris et al., 2004)
and the immune pathways in Reactome (Croft et al., 2011), indi-
cated that networks using KEGG immunological pathways for
training performed better than those using the alternative training
sets. Full details of the method and its implementation can be
found in the Computational Methods and in previous publica-
tions (Hibbs et al., 2007; Huttenhower et al., 2006, 2009).
This approach thus provides new information relevant to the
relationships in each immunological pathway based on how
well the input datasets recapitulate known relationships within
the pathway. The method uses the quantification relevant for
various types of datasets (e.g., high throughput binding evidence
for physical protein associations, normalized correlation be-
tween each pair of genes in every microarray dataset, etc.; see
the Supplemental Computational Methods) in assessing each
dataset’s relevance. For example, correlated expression of
beta chain of MHC class I molecules (B2M) and peptide trans-
porter involved in antigen presentation (TAP1) in amicroarray da-
taset will increase the weight of that dataset in generating the
‘‘antigen processing and presentation’’ network, because these
two molecular entities are part of the corresponding KEGG
pathway. Novel functional relationships between molecular en-
tities in the context of that pathway are then predicted, taking
into account the computed relevance of each dataset (Figure 1).
Along with the 15 pathway-specific networks, we also con-
structed an ‘‘ImmuneGlobal’’ network that represents the aggre-
gate of the information in the individual pathway networks. The
resulting ImmuNet functional networks provide researchers
with a data-driven summary view of the human immune system
through the aggregate Immune Global functional network. In
addition, when information most relevant to a specific immuno-
logical pathway is sought, ImmuNet provides this more granular
context of specific immune pathways (e.g., chemokine signaling
pathway functional network).
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Figure 1. ImmuNet Development and
Selected Applications
Data from more than 38,000 experiments
(including mRNA expression, protein interaction
assays, and phenotypic assays) were collected
from public repositories and systematically pro-
cessed (see Supplemental Computational
Methods). These data and curated immune
pathway prior knowledge fromKEGGwere used as
input to infer 15 immune-specific functional rela-
tionship networks and an overall Immune Global
context averaged network. Each immune-specific
functional network predicts functional association
between molecular entities (genes or proteins)
specific to a particular immune biological process
(e.g., antigen processing and presentation). Im-
muNet leverages this massive data compendium
to predict novel immune process or immune dis-
ease associations. See Supplemental Computa-
tional Methods for full information on the data
compendium and integration.To determine the ability of ImmuNet to capture immune pro-
cess-specific interactions, we conducted a cross-validation-
based evaluation by using statistically rigorous, well-established
approaches (Geisser, 1993; Hastie et al., 2011). We withheld a
randomly selected third of the known pathway-determined im-
mune relationships and integrated the data compendium as if
this held-out information were unavailable. We then tested the
ability of the resulting network to predict the held-out relation-
ships. The procedure was repeated with each non-overlapping
third of the data. Thus, ImmuNet’s accuracy in predicting this
held-out information provided an estimate of its ability to make
novel predictions.
ImmuNet was able to accurately recapitulate relationships
among molecular entities that were held out from each of the
15 KEGG immune pathways (Figure 2A). The predictions ob-
tained with this data-driven approach represent a dramatic
improvement over chance (range p = 10266 to p = 1010, see Ta-
ble S1 for all p values and associated methods for the computa-
tion of the statistical significance). This analysis indicates that the
ImmuNet integration can correctly make predictions that were
not used in its construction and therefore can make novel
predictions.
We also compared the results obtained from ImmuNet to those
obtained from two non-immune networks built using well-estab-
lished approaches: the network comprised of experimentally
determined protein-protein physical interactions (PPI) curated
in the BioGRID database (Stark et al., 2006) and a non-immune-
specific Bayesian functional integration network (Human Global,
see Supplemental ComputationalMethods), which is an updated
version of a previously reported network (Huttenhower et al.,
2009), that is now based on the exact data compendium used
for generating ImmuNet. The Immune Global Network signifi-
cantly outperformed the experimental physical interaction PPI
network (20% improvement, p < 3 3 109; Wilcoxon signed-Immunity 43, 605–614, Serank test) as well as the Human Global
network (17% improvement, p < 2 3
108, Figure 2B). The Immune GlobalNetwork is based on data from the PPI network as well as other
data sources, so this comparison supports the power of this
approach in integrating insight contained in extremely diverse
typesofmeasurements. The improvedability of the ImmuNet net-
works to predict the KEGG immunological pathways under-
scores the robustness of the Bayesian integration to extract rele-
vant pertinent information and increase predictive accuracy
despite the heterogeneous and noisy nature of the underlying
data compendium.Overall, these results demonstrate that devel-
oping an immunologically based network improves the ability to
predict new immune-specific functional relationships amongmo-
lecular entities.
To investigate whether biological datasets stemming from
non-immunological studies contain immune-related signals, we
assessed the difference in performance for the ImmuNet net-
works generated using the entire compendium of data with those
generated using only data from immune-related experiments
(see Supplemental Computational Methods). Using the hold-
out of known examples procedure as described above, our
results (Figure S1) showed a 12% improvement in performance
(p < 3 3 109; Wilcoxon signed-rank test) over networks
generated using only data from immune-related experiments,
demonstrating the benefit of using the complete compendium
of experimental data. Because Bayesian integration is able to
automatically infer each dataset’s relevance to immune biology
or a specific immune pathway, using the larger, more complete
data compendium becomes a prime opportunity for generating
more informative networks.
Interrogating the ImmuNet Resource
We have shown computationally that ImmuNet can provide new
insight into immunological relationships among molecular en-
tities. In order to make this a flexible and convenient resource
for hypothesis generation by immunologists, we have developedptember 15, 2015 ª2015 Elsevier Inc. 607
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Figure 2. ImmuNet Accurately Recapitulates Known Functional
Relationships in Immune Pathways
(A) ImmuNet networks were evaluated via 3-fold cross-validation. For each
pathway, one-third of the pathway data was iteratively omitted when con-
structing the network and the accuracy of this network in predicting the held-
out information was tested. The panel shows the successful recovery of held-
out immune data when we used the standard area-under receiver operator
curve (AUC) metric that reflects both specificity and sensitivity (Hastie et al.,
2011). Bar plots represent the mean ± SEM of the three cross-validations.
(B) Using 3-fold cross-validation, the performance of the ImmuNet global
network was compared to two standard non-immune-specific networks,
BioGRID PPI network and a functional integration Human Global network.
Boxplots represent the AUC performance distribution of each network at
recovering known immune relationships (from the 15 KEGG contexts) that
were held out during the training of each network. ImmuNet significantly out-
performed the other two networks. p values are based on Wilcoxon signed-
rank test.
See also Figure S1 and Table S1.
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Figure 3. Illustration of the Use of Immune-Specific Functional
Networks
(A) High-confidence subnetwork obtained by querying the ImmuNet hemato-
poietic cell lineage network with IFNAR1 (Interferon receptor 1) and FAS (Cell
surface death receptor). The subnetwork obtained predicted that the pro-
cesses reflected by the query genes are functionally related to PTGER2 and
MNDA. The visualization parameters used to generate the graph shown are
minimum relationship confidence = 0.61 and maximum number of genes = 21.
(B) The relationship of MNDA to cell death in the context of antiviral responses
was evaluated by comparing its induction by infection of DCs by IAV that
induce cell death (seasonal viruses NC/99; TX/91) or do not induce cell death
(pandemic viruses Brevig, Cal/09) in these cells. Data shown is 8 hr after
infection at MOI = 1, normalized to the levels obtained with vehicle-treated
cells. Notably, MNDA is differentially induced by the two virus groups. Bar
plots represent the mean ± SEM gene expression fold-change of three repli-
cate infections.
See also Table S2.an intuitive interface and tools to allow researchers to address a
wide variety of questions that pivot on predicting functional rela-
tionships. We illustrate how ImmuNet can be applied to generate
hypotheses that might help guide further investigation.
The production of type I interferons and the activation of
cellular apoptosis have both been associated with the immune
responses to influenza A virus (IAV) infection. Interferons, which
are released by cells infected by pathogen or cells stimulated by
activation of pathogen-associated molecular pattern (PAMP) re-
ceptors, act on other cells to inhibit virus infection and replication
(Koerner et al., 2007). Cell apoptosis initiated during antigen pre-
sentation has been proposed to impair IAV dissemination (Mok
et al., 2007) and to enhance T-cell-mediated immunity via anti-
gen cross-presentation (Albert et al., 1998). We have found
that when human dendritic cells were infected in vitro with
various H1N1 IAV strains, the seasonal viruses, but not the
pandemic viruses, induced cell death (Hartmann et al., 2014).608 Immunity 43, 605–614, September 15, 2015 ª2015 Elsevier Inc.To further our understanding of the relationship of cell death
and interferon-mediated antiviral responses, we queried Immu-
Net to identify new targets that connect these processes.
To interrogate the ImmuNet resource, we selected representa-
tive genes or proteins for each process that were then used to
assemble a subnetwork showing their overall shared relation-
ships to molecular entities not included in the query. The use
of ImmuNet thus provides a bridge from the researcher’s own
knowledge to the inference of novel, relevant global-data-
derived hypotheses. Although multiple molecular entities can
be used for any query, for simplicity we restrict this example to
two entities. To address interferon and cell death pathway cross-
talk in antiviral responses, we queried ImmuNet using IFNAR1, a
type I interferon receptor component, to represent interferon
signaling, and FAS, the cell surface death receptor, to represent
cell death processes. The predicted subnetwork resulting from
this query is shown in Figure 3A. One molecular entity that was
retrieved, the prostaglandin receptor PTGER2, suggested the
possible involvement of prostaglandins in the modulation of
cell death and interferon-mediated antiviral processes. Support-
ing this ImmuNet-derived inference, a recent report in this journal
has demonstrated that IAV upregulates production of the
PTGER2 ligand, prostaglandin E2 (PGE2), to evade host type I
interferon-mediated immunity and to decrease apoptosis in alve-
olar macrophages (Coulombe et al., 2014).
This example also shows how one can use ImmuNet to
generate global-data-driven hypotheses for future study. For
example, the subnetwork showed that myeloid cell nuclear dif-
ferentiation antigen (MNDA) was linked to both FAS and IFNAR1.
MNDA was originally identified by its association with myeloid
leukemia (Briggs et al., 2006; Hofmann et al., 2002; Pradhan
et al., 2004). MNDA is a member of the Pyrin and HIN domain
(PYHIN) family of proteins, othermembers of which have recently
been identified as viral pathogen recognition receptors (PRR)
(Connolly and Bowie, 2014; Schattgen and Fitzgerald, 2011).
Based on the ImmuNet-predicted subnetwork and subsequent
review of the literature, we speculated that MNDA might repre-
sent a PRR that functions at the interface of interferon and cell
death antiviral processes. Because specific IAV strains differ in
their capacity to induce cell death in dendritic cells (Hartmann
et al., 2014), this hypothesis motivated us to compare the induc-
tion of MNDA expression in IAV strains that induce or do not
induce cell death. We found experimentally that MNDA expres-
sion was induced only by the two pandemic IAV strains, which
do not cause cell death in these cells, and not by the cell-
death-inducing seasonal IAV strains (Figure 3B, see Supple-
mental Computational Methods). These results are consistent
with the hypothesis generated from ImmuNet that MNDA is func-
tionally related to cell death and antiviral processes, and suggest
that further study of this molecular target and its role in the differ-
ential response to IAV infection in these cells is warranted.
ImmuNet also allows the relative importance of the specific
datasets that underlie inferred relationships to be reviewed by
clicking on the corresponding edge in the network. Notably, for
both PTGER2 and MNDA, the vast majority of datasets underly-
ing their predicted relationships to FAS, as well as to other nodes
in this subnetwork, have little apparent relevance to immunology
(see Table S2 for an example). Thus the use of ImmuNet allows
the researcher to rapidly develop global-data-driven hypotheses
based on a wealth of experiments that would otherwise never be
considered in order to help prioritize directions for further study.
Using ImmuNet for Gene Signature Prediction
We next show an application of ImmuNet to investigate gene
program responses to virus infection. After cell infection,
different viruses elicit specific host gene expression responses
(Huang et al., 2001). The specificity of the responses results in
part because each virus can differ in its ability to suppress partic-
ular host defense mechanisms via viral antagonists. Virus im-
mune antagonists, which help pathogenic viruses to evade the
host immune response, differ in their molecular targets, even
among closely related viruses (Garcı´a-Sastre, 2011; Nemeroff
et al., 1998; Noah et al., 2003). In order to facilitate the identifica-
tion of viral immune antagonistmechanisms, it would be useful to
identify ‘‘expected’’ response genes that are missing in the
response to a specific virus. These differential-absence signa-Imture genes represent candidate targets for novel immune antag-
onism mechanisms. Finding a differential absence signature for
a particular virus experimentally would require, in principle, com-
parison of the gene response to the virus of interest with the
expression patterns elicited by a myriad of possible immune-
response-eliciting stimuli. Such an undertaking would be
arduous, and prioritizing and interpreting any results obtained
would be a daunting bioinformatics project. We show that using
ImmuNet to draw evidence from the massive data already avail-
able in the public domain greatly facilitates this type of inquiry.
To illustrate this approach, we focused on the H1N1 influenza
A/New Caledonia/99 virus strain (NC/99). Beginning with a seed
set of 183 genes that characterizes the early immune response to
NC/99 infection in monocyte-derived dendritic cells (Zaslavsky
et al., 2013), we used ImmuNet and the support vector machine
(SVM) algorithm (Noble, 2006) to generate a prioritized list of pu-
tative differential-absence genes (Figure 4A). The SVM classifier
identifies which ImmuNet functional network patterns are pre-
dictive of genes that are functionally similar to the seed genes.
That is, the classifier learns the functional network connectivity
properties that characterize the NC/99 early response genes
and applies them to predict other genes that would be expected
to be regulated (see the Computational Methods).
We selected the top 16 genes identified by the classifier that
were highly connected to the NC/99 response but were not regu-
lated by the NC/99 infection at any time point. To support the hy-
pothesis that this NC/99 differential absence signature is en-
riched in genes that are subject to NC/99 viral antagonism
mechanisms, we quantified the response of these top 16 Immu-
Net-predicted differential absence genes to infection by New-
castle Disease Virus (NDV), an avian pathogen that lacks human
immune antagonist activity (Park et al., 2003a, 2003b; Zaslavsky
et al., 2010). We first established that infection of monocyte-
derived dendritic cells with either NC/99 or NDV yielded compa-
rable infectivity (Figure 4B, top panel, see the Supplemental
Computational Methods) and elicited an antiviral response, as
indicated by the induction of the antiviral gene MX1 (Figure 4B,
bottom panel). Of the 16 genes included in the ImmuNet-pre-
dicted NC/99 differential absence signature, seven genes were
induced in NDV-infected cells at 8 hr, but were not induced by
NC/99 at either 4 hr (data not shown) or 8 hr (Figure 4C, left).
We also evaluated the chances of finding this high a proportion
of differentially regulated genes without benefiting from the pre-
dictive ability of ImmuNet. To assess this, we selected genes that
were not induced by NC/99 infection, but were annotated in
Gene Ontology (GO) as immunological genes. Only 2% of this
set were reported as regulated by NDV (Zaslavsky et al., 2010),
in comparison with the 44% of ImmuNet-predicted genes that
were regulated (p < 3 3 1016, proportion difference 99% CI
[0.07, 0.77], Pearson’s chi-square test).
Among the immune genes that were hypothesized to be spe-
cifically targeted by NC/99 antagonism, we found IFI6, which has
been previously implicated in more targeted antiviral specificity
(Schoggins et al., 2011), and BST2 (also known as tetherin),
which is an interferon inducible host protein that, when not sup-
pressed, interferes with budding of IAV (Garcı´a-Sastre, 2011).
Furthermore, ImmuNet identified interesting targets for study
that are not known to have immunological roles. Notably, three
of the ImmuNet-predicted differential absence genes that weremunity 43, 605–614, September 15, 2015 ª2015 Elsevier Inc. 609
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Figure 4. Functional Networks Predict Specificity of Influenza Viral Infection
(A) Pathogenic viruses, such as the NC/99 IAV strain, have developed immune antagonist mechanisms to suppress components of the antiviral response gene
program. Genes induced in human DCs infected with NC/99 (Zaslavsky et al., 2013) were used as input for an ImmuNet-based method to predict differential
absence genes. With these 183 genes as positive examples, an SVM classifier was trained to identify genes in the Immune Global network that were closely
related to the seed set but were not induced by NC/99. The absence of these ‘‘expected’’ genes identified them as candidates for NC/99 immune antagonist
mechanisms.
(B) DCs were infected at MOI = 1 with NC/99 or NDV. Infectivity was assayed by immunostaining of viral proteins (NP for NC/99 and HN for NDV). Antiviral gene
MX1 was induced by each virus, assayed by RT-PCR, indicating virus detection and initiation of cellular responses.
(C) Expression levels of the 16 SVM-classifier top-ranked ‘‘expected’’ absence genes 8 hr after NC/99 or NDV infection were assayed. Seven of the predicted
genes were significantly higher after NDV infection at 8 hr (p < 0.05). Data represent mean ± SEM from three independent experiments, each performed in
triplicate.regulated by NDV were not annotated to immunological pro-
cesses in GO. This indicates the value of ImmuNet in expanding
the known universe of genes and proteins involved in immuno-
logical processes.
Overall, this analysis indicates that ImmuNet provides an effi-
cient and specific approach to use the global research data com-
pendium to guide studies toward identifying virus-strain-specific
immune antagonist mechanisms. In order to allow the non-
computational immunology researcher to perform this type of
classifier analysis, we have developed a user-friendly SVM tool
available through the ImmuNet website.
Using ImmuNet to Predict Disease-Associated Genes
We next examined whether ImmuNet networks could be used as
a functional summary of the public data compendium to facilitate
the identification of disease-associated genes. We implemented
a set of SVM classifiers to predict disease-associated genes for
immune-related disease groups, including inflammatory bowel610 Immunity 43, 605–614, September 15, 2015 ª2015 Elsevier Inc.disease (IBD), rheumatoid arthritis (RA), and common variable
immune deficiency (CVID). In order to build each disease classi-
fier, the genes known to be associated with the disease were
selected from the Online Mendelian Inheritance in Man catalog
(OMIM) (Table S3; Hamosh et al., 2005). Genes used as negative
examples for training were selected at random from all non-
immune-disease-associated genes in OMIM. The classifier
then provided the ability to rank all genes in the ImmuNet
resource by their probability of being associated with the disease
of interest.
The validity of the predictions and the comparative perfor-
mance of the immune-specific ImmuNet network with the PPI
network and the human global non-immune-specific Bayesian
data integration were tested using the cross-validation approach
described previously. In this systematic cross-validation evalua-
tion, we iteratively withheld a subset of known disease genes
from the OMIM training sets and assessed how well the predic-
tions recapitulated these held-out known disease-associated
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Figure 5. Immune-Specific Functional Net-
works Accurately Predict Gene-Disease
Associations
To predict disease-associated genes, SVM clas-
sifiers were trained using ImmuNet with OMIM
genes annotated to CVID, IBD, and RA.
(A) Results of 3-fold cross-validation, in which each
classifier was trained without one-third of the
known positives, and the accuracy of predicting
this held-out information was evaluated by
receiver-operator AUC.
(B) Prediction of GWAS-associated genes by
ImmuNet classifiers. The relationships of the SVM
classifier score and reported GWAS-associated
genes were determined. The graph shows differ-
ences in the probability density of genes reported
as GWAS associated in comparison with other
genes in the network. Genes with high SVM scores
were highly significantly enriched in reported
GWAS-associated genes for all three diseases.
(C) Prediction of reported IBD eQTL genes by
ImmuNet IBD classifier. The relationship of the
SVM classifier scores and reported eQTL genes
was determined. The graph shows a significant
difference in the probability density of genes
identified by eQTL analysis in comparison with
other genes in the network. See also Figure S2 and
Table S3.genes not used in building the evaluation classifier. The ImmuNet
predictions showed high accuracy (AUCs = 0.75 to 0.88; see
Figure 5A) and significantly outperformed those using the PPI
network (p < 0.007; Wilcoxon signed-rank test) and the non-im-
mune-specific functional network (p < 0.005, Figure S2A). This
evaluation suggests that the ImmuNet-based disease classifiers
should be accurate in predicting new disease-associated genes.
In order to evaluate further the usefulness of this approach for
generating disease gene predictions, we used a curated NHGRI
catalog of GWAS-identified causal genes (Welter et al., 2014) to
test whether GWAS-identified genes were enriched among the
highest-confidence ImmuNet disease-associated predictions.
We evaluated ImmuNet gene predictions for IBD, RA, and
CVID. As shown graphically in Figure 5B, we found that each
set of the GWAS genes was highly enriched among the highest
ranked predictions for its respective classifier (CVID p < 7.5 3
105; IBD p < 1.3 3 1051; RA p < 4.1 3 1059 by PAGE rank-
based enrichment test [Kim and Volsky, 2005]). We also studiedImmunity 43, 605–614, Sewhether the ImmuNet disease-associated
gene classifier was useful for predicting
expression quantitative trait loci (eQTL)
genes. We focused on the complex
multifactorial disease IBD (Neurath and
Finotto, 2009). We compared the Immu-
Net classifier-generated IBD gene list to
previously identified IBD eQTLs (Kabak-
chiev and Silverberg, 2013). Among the
highest ranked ImmuNet IBD classifier
predictions, reported eQTL genes were
significantly enriched (p < 0.0001, PAGE
rank-based enrichment test, Figure 5C).
These results indicate that ImmuNet pro-
vides a useful computational approachfor identification of candidate disease-associated genes based
on GWAS data that can complement eQTL data and be espe-
cially useful for prioritizing potential targets when eQTL data
are not available.
These three independent assessments (hold-out cross-valida-
tion, GWAS prediction, and eQTL prediction) indicate that
ImmuNet is a powerful functional-genomics-based framework
to facilitate understanding the genetics of immune diseases.
The user-friendly interface to apply the SVM classifier prediction
engine to any immune-related disease of interest should facili-
tate wide application of the approaches described.
DISCUSSION
Computational analyses of large collections of experimental data
harbor great potential for leveraging the relevant information in
public data to make novel biological inferences far beyond those
generated in each dataset’s original analysis and publication.ptember 15, 2015 ª2015 Elsevier Inc. 611
Here, we introduced a probabilistic framework that can effec-
tively utilize the global research output of the biomedical com-
munity to address targeted immunology research questions
by identifying immunologically relevant signals hidden in diverse
human large-scale data. To enable any biomedical researcher to
easily explore and utilize these large data collections, we made
ImmuNet and its associated analysis tools publicly available for
the immune research community through an intuitive user-inter-
active website at http://immunet.princeton.edu/.
Through rigorous and systematic evaluations, we demon-
strated that ImmuNet was able to accurately identify members
of immune pathways as well as genes involved in immune
diseases. The immune-specific aspect of the probabilistic
integration was important for these tasks, because ImmuNet
substantially outperformed non-immune-focused probabilistic
integration or physical interaction networks. Further, we demon-
strated that ImmuNet, which is trained with immunological path-
ways, extracts insight relevant to immunology from datasets not
generated for immunological purposes. For example, in our
illustration of the use of ImmuNet to study responses to influenza
A virus, ImmuNet utilized datasets that would not initially seem to
contain relevant immunological information, such as gene
expression studies of medulloblastoma metastasis or prostate
cancer cell lines exposed to DNA-methylation inhibitors. Overall,
we found that integration focused only on datasets collected in
studies directly relevant to immunology was less accurate than
ImmuNet’s integration of the entire data compendium. This
finding demonstrates that immunologically relevant insight is
contained in non-immunological public data, and it can be
extracted by immunologically focused probabilistic integration.
The resulting immune-specific functional networks aid in the
interpretability of immune disease genome-wide association
studies by leveraging functional genomics synergistically with
quantitative genetics.We demonstrated the usefulness of Immu-
Net in prioritizing GWAS-reported genes and in predicting dis-
ease-associated eQTL-confirmed genes. Major challenges still
exist in identifying disease-linked loci due to biases in verification
of GWAS-implicated loci linked to intergenic SNPs, especially
with regard to bias for the nearest gene. Our customizable,
web-accessible engine, which prioritizes genes in such loci
based on functional genomic information, complements the
use of physical distance and improves prioritization for experi-
mental validation.
As genomic data collections continue to grow, our immune-
specific probabilistic framework will be updated to continue to
provide a flexible and intuitive approach for exploring these
data to make hypotheses about immune biology and the molec-
ular basis for immune diseases. In its current release, ImmuNet
might have less relevance for some aspects of immunology,
such as cell-cell interaction over space and time via the
action of cytokines, because these relationships might not be
well captured by public data. However, the applicability of Immu-
Net to wide-ranging areas of immunology should grow with
incorporation of continually increasing public big data. Our
framework enables biomedical researchers to mine these data
from an overall immunology-relevant perspective as well as
from the perspective of specific immune processes. In addition,
our framework makes it easy for the researcher to utilize SVM
machine learning to predict genes associated with any specific612 Immunity 43, 605–614, September 15, 2015 ª2015 Elsevier Inc.disease or condition based on an ImmuNet-generated network.
By enabling immune researchers from diverse backgrounds to
intuitively leverage these valuable but noisy and heterogeneous
data collections, ImmuNet has the potential to accelerate dis-
covery in immunology.
COMPUTATIONAL METHODS
Immune Functional Relationship Networks
Integrated functional relationship networks summarize heterogeneous collec-
tions of genome-scale data into a concise graph representation. In this graph,
molecular entities (genes, proteins) are nodes. The edge weights between no-
des represent the probability that these molecular entities function together
within a biological process. ImmuNet functional networks are generated by
Bayesian data integration, which assesses the conditional probability that
individual data sources (e.g., microarray experiments, protein-protein interac-
tion data, etc.) contain evidence for gene relationships based on a training set
of positive and negative examples (Pearl, 1988; Troyanskaya et al., 2003). Intu-
itively, this process assesses the accuracy and coverage of each data source,
automatically down-weighting noisy datasets and experiments that are simply
not relevant to the immune processes used for training the network. Bayesian
inference then predicts the pair-wise posterior probabilities of functional rela-
tionships between all genes based on these per-dataset weights and behavior
of these genes in the corresponding datasets. By choosing the training exam-
ples appropriately, we can generate networks that are specific to particular
immunological pathways. This context specificity improves accuracy (Hutten-
hower et al., 2009) and provides users an opportunity to ‘‘summarize’’ the
heterogeneous data collections focusing on specific areas of interest. To train
networks to identify novel relationships in immunological research areas, we
used 15 curated, immune-related KEGG pathways (Ogata et al., 1999) and a
massive data compendium to generate 15 immune context networks. We
also generated a context-averaged summary network (Immune Global), based
on the 15 specific networks.
A network can be trained with any available set of annotated immunological
relationships among molecular entities. We compared the predictive capacity
of networks trained with immune relationships from Gene Ontology (Harris
et al., 2004), Reactome (Croft et al., 2011), and KEGG. Networks trained on
KEGG outperformed those based on the other training sets (Figure S2B).
The description of the training examples, data sources, and generation of Im-
mune Global are provided in the Supplemental Computational Methods.
Evaluation of ImmuNet Functional Relationships
We evaluated the ability of ImmuNet to capture immune-process-specific
interactions by conducting a 3-fold cross-validation for each of the 15 KEGG
immune pathways. The total set of molecular entities present in the reference
pathway was randomly portioned into three sets. In each of the three cross-
validation runs, a functional relationship network was generated using a
training set limited to molecular entities present in two of the three subsets.
The held-out third of the training set was used for evaluating the performance
of the network generated using the other two-thirds (as measured by the area
under the receiver operator characteristic curve [AUC]). Additionally, for each
cross-validation, a context-averaged Immune Global network was generated
and evaluated using the 15 networks of the corresponding cross-validation run
(see Supplemental Computational Methods).
Gene Signature Prediction for Virus Infection
NC/99 Gene Response Signature
We identified genes characteristic of the early transcriptional response to
H1N1 influenza A/New Caledonia/20/1999 (NC/99) infection in monocyte-
derived dendritic cells (Zaslavsky et al., 2013). In that study, microarray
profiling was used to select 183 genes that were differentially upregulated at
the 4 hr post-infection time point. These genes were used as the input seed
set for further analysis with ImmuNet.
SVM Classifier
SVM (Support Vector Machine) is a supervised machine learning method that
uses a training set of examples belonging to two classes and a collection of
relevant data/features (ImmuNet networks) to build a classification scheme
that assigns each new example to one of these classes (Cortes and Vapnik,
1995). In our case, the two categories represent genes that either are related
to a specific immune response/disease (positive examples) or are unrelated
to this group (negative examples). In our previous work, we have demonstrated
that functional networks can be used as input to machine learning methods,
such as SVM, to accurately predict gene knockout phenotype, biological pro-
cess membership, and disease association (Guan et al., 2010; Wong et al.,
2012). Intuitively, gene-gene interaction probabilities derived by functional
networks provide an accurate, integrative summary of high-throughput data,
allowing machine learning methods to identify predictive gene connections
related to the trait or disease of interest.
We leveraged ImmuNet networks as input to the SVM classifier to predict
genes that show network properties similar to the set of genes that charac-
terizes the early transcriptional response to NC/99 infection. Genes that were
differentially upregulated in response to NC/99 infection (183 genes, as
above) comprised the positive examples for our training set. Training nega-
tives used the same negative set for disease SVM classifiers, excluding
genes that have been identified as differentially regulated within the NC/99
transcriptional response at any time point. The network edge probabilities
in the Immune Global functional network were used in the feature vector
for supervised training of a linear SVM model. The SVM classifier was eval-
uated using 3-fold cross-validation. Seven cost parameters were tested for
each classifier (C = 10n: 3 R n R 3), and the best-performing parameter
for each disease classifier was used. The resulting SVM scores for each
gene were then converted to probabilities by a sigmoid transformation (Platt,
1999).
Disease Prediction and Evaluation
To train SVM disease prediction classifiers, we utilized the ontological
structure of Disease Ontology (Schriml et al., 2012) with the annotated genes
in OMIM (Hamosh et al., 2005). OMIM-annotated genes were associated to
their corresponding Disease Ontology terms, and the ontology structure was
used to aggregate genes annotated to any branch of each disease subgroup
studied. Using Disease Ontology terms, we identified nine immune disease
subgroups that had six or more associated positive genes for training (see Ta-
ble S3). Training negatives were selected randomly from genes associated
with some OMIM disease term, excluding immune disease-annotated genes.
Because there are GWAS data available for CVID, which is annotated in Dis-
ease Ontology as a child term of one of the nine disease categories, we trained
a separate classifier for CVID (Table S3). The network edge probabilities in the
Immune Global functional network were used in the feature vector for super-
vised training of a linear SVM model. Each SVM classifier was generated
and evaluated using cross-validation, with cost parameters and conversion
to probability of disease association as described above. Disease-associated
genes predicted by these classifiers were evaluated against GWAS and eQTL
catalogs, as described in the Results.
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